Table 4 Susceptibility of P. falciparum to antimalarials in Burkina Faso.
From: Rapid urban malaria appraisal (RUMA) I: Epidemiology of urban malaria in Ouagadougou
Year | Drugs tested | Study sites | Urban/Rural | Authors | Failure rate In vivo |
|---|---|---|---|---|---|
1982–1986 | CQ (in vitro & in vivo) | Koudougou | Urban | [36] | First case found |
1988–1989 | CQ | Koudougou Zaghtouli Dori Banfora Fada N'Gourma | Urban Rural Urban Rural Rural | [37] | 25% |
1988 | CQ | Zaghtouli | Rural | [38] | 18.7% |
1989 | CQ | Dapelgo | Rural | [38] | 20.2% |
1982–1991 | CQ, SP, quinine, MP (in vitro) | Ouagadougou Bobo-Dioulasso | Urban | [39] | 6–15.8 % |
1990–1992 | CQ, SP (in vitro), quinine, halofantrine hydrochloride MP, | Ouagadougou and its neighbouring villages | Urban Rural | [22, 40-42] | CQ & SP: 8.1–24.4% Others: 0% |
1993 | CQ | Ouagadougou | Urban | [43] | 25% |
1995–1996 | CQ, quinine, MP (in vitro) | Bobo-Dioulasso | Urban | [44] | CQ: 19–20% M:2–9.6% |
1992–1998 | CQ, AQ, quinine, halofantrine MP | Ouagadougou | Urban | [45] | AQ:4.3% & 2.2 % in 1997 CQ:8.5% in 1992, CQ:20% in 1994 H: 7.9% in 1997 (in vitro) MP: 0% in 1997 (in vitro) Q: 0.9% in 1995 MP+H:7.6% in 1997 |
1999–2002 | CQ & SP | Bobo-Dioulasso | Urban | [46] | CQ:18% SP: < 1% |